Skip to main content
Top
Published in:

01-10-2019 | HIV Drug | Clinical study

Neural tube defects after exposure to antiretrovirals

Published in: Reactions Weekly | Issue 1/2019

Login to get access

Excerpt

Neural tube defects (NTDs) have been reported to pharmacovigilance databases after exposure various to antiretrovirals (ARVs) including dolutegravir (DTG), according to findings of an analysis published in Clinical Infectious Diseases. …
Metadata
Title
Neural tube defects after exposure to antiretrovirals
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2019
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-69710-0